Elekta and Medical Intelligence Form International Distribution Partnership Creating Complete Solutions for Stereotactic Radiation Treatments
Posted on: Wednesday, 20 July 2005, 03:01 CDT
STOCKHOLM, Sweden, July 20, 2005 (PRIMEZONE) -- Elekta, a world leading supplier of clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders, today announced a global distribution agreement with Medical Intelligence (MI), a single-source supplier of high-precision patient fixation systems.
Integrating key elements of MI's radiotherapy and patient positioning systems into its own product portfolio, the agreement reinforces Elekta's position as the world's most comprehensive provider of complete solutions for stereotactic radiation treatment throughout the body. In addition to commercial distribution, the agreement includes plans for future product developments that will significantly advance the ability of clinical specialists to precisely and easily target tumor cells.
Among the products from MI is HexaPOD(tm) RTC, an image guided robotic patient positioning system that allows for sub millimeter patient positioning with six degrees of freedom (6D). 6D means that the system can correct rotational errors in patient positioning as well as translational errors, making it ideal for the very high accuracy required for stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT).
HexaPOD will be available for use with all Elekta digital linear accelerator systems, but by integrating HexaPOD with Elekta Synergy(r) S for image-guided SRS and SRT, synergistic benefits will be created, enabling clinical staff to reliably and accurately position patients for treatment with a previously unattainable level of certainty. Elekta Synergy S includes X-ray volume imaging, the first system to allow three-dimensional imaging of the tumor and its surrounding soft tissues at the time of treatment.
As Professor Frederik Wenz MD, of Mannheim Medical Center and University of Heidelberg, Germany, explains: "While X-ray volume imaging with Elekta Synergy(r) enables the detection of patient positioning errors in all areas of the body, MI's HexaPOD and patient immobilization products make corrections of patient positioning in six degrees of freedom a clinical reality. Bringing these tools together is therefore a logical development that instantly creates a powerful system to reliably and easily perform detection and correction of positioning errors during critical radiation treatments."
In addition to positioning systems, Elekta will also distribute MI's patient immobilization devices, complementing the company's stereotactic experience. MI's BodyFix(r), for example, is one of the most accurate and comprehensive patient immobilization and positioning system available today.
Summarizing the partnership with Elekta and the synergies achievable with the two product portfolios, Dr. Michael Vogele, CEO of MI said: "Medical Intelligence offers unique and innovative radiation oncology solutions in terms of automatic patient positioning with 6 degrees of freedom, improving clinical workflow and patient confidence. The strategic alliance with Elekta made so much sense for both companies; while MI enhances Elekta's stereotactic portfolio, MI gains the strength needed to export our radiation therapy solutions to a broader worldwide customer base. In the end, however, it is the clinical specialists and patients themselves who will realize the greatest benefits from this partnership."
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife(r) for non-invasive treatment of brain surgery and Elekta Synergy(r) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1,700 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.
About Medical Intelligence
Medical Intelligence is a world-leading supplier of advanced and innovative Radiation Oncology and interventional guidance products for precise, reliable patient positioning and treatment. Product lines include among others non-invasive immobilization and positioning systems, 6D robotic treatment couches and robotic targeting devices.
All Medical Intelligence Radiation Therapy solutions are engineered to fit today's requirements from diagnostics through treatment including Image Guided Radiation Therapy (IGRT) and Precise Radiation Therapy treatment machines.
Rigorous Radiation Therapy treatment modalities require precise patient positioning and immobilization. Medical Intelligence provides the tools and fundamentals enabling reliable positioning while preserving patient comfort and confidence. The company's commitment to excellence and quality is reflected in the worldwide service and support.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=117059&fn=wkr0001.pdf PDF version
CONTACT: Elekta Product inquiries Amanda Deighton, Product Manager Tel: +44 1293 654413 e-mail: amanda.deighton@elekta.com
Medical Intelligence Torben Mersebach, Project Manager Tel: +49 82 32 96 92 0 e-mail: t.mersebach@medint.de
Claudio Karpf, Product Manager Tel: +49 82 32 96 92 0 e-mail: c.karpf@medint.de
Elekta AB International investor inquiries Peter Ejemyr, Group VP Corporate Communications Tel: +46 733 611 000 e-mail: peter.ejemyr@elekta.com
U.S. investor inquiries Elekta, USA Lars Jonsteg, VP Investor Relations North America Tel: +46 708 78 37 35 e-mail: lars.jonsteg@elekta.com
Copyright © 2005 PrimeZone Media Network, Inc.
Source: PrimeZone Media Network
Related Articles
- Elekta and RAD Technology Medical Systems Team Up to Place First Temporary Modular Radiation Oncology Center in Northern California
- Varian Medical Systems Adds RapidArc(R) and Image Guidance to New Low Energy Treatment Platform for Radiation Therapy in International Cancer Clinics
- American Medical Systems Announces GreenLight Laser Therapy Events at AUA 2008 in Orlando
- Eclipse(TM) Proton Scanning Algorithm From Varian Medical Systems Receives FDA Clearance
- Spring Medical Systems' SpringLabs Strengthens Market Share
- Elekta Acquires 3D Line Medical Systems
- American Medical Systems Announces Settlement With Celsion Corporation
- Calypso(R) Medical to Collaborate With IMPAC Medical Systems on Radiation Therapy Solutions for Organ Motion Management
- VA Contracts With Elekta and IMPAC for Radiation Oncology Systems and Healthcare IT Solutions
- ACIST Medical Systems Announces The ACIST CVi Product Introduction at the TCT: The ACIST CVi - Trust Experience. Rely on Innovation
 |
 |
User Comments (0)
RSS Feeds